Umbilical Cord Blood Stem Cells Storage - Global Market insights and Sales Trends 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Umbilical Cord Blood Stem Cells Storage - Global Market insights and Sales Trends 2024
Umbilical Cord Blood Stem Cells are called "zero-year-old cells". They can systematically improve the functions of various organs and have extremely strong regeneration and repair capabilities. They can replace bone marrow for stem cell transplantation and treat blood and immune deficiency diseases such as leukemia and aplastic anemia. Currently, Umbilical Cord Blood Stem Cells can be used to treat more than 80 diseases in medicine.
Global Umbilical Cord Blood Stem Cells Storage market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Anti-Tumor Treatment and Antibacterial Treatment are the major drivers for the industry."&
Mesenchymal stem cells are widely present in human tissues and organs, especially in fetal perinatal tissues (placenta, umbilical cord, etc.). They are very abundant and have very low immunogenicity. And because neonatal stem cells are mainly derived from the placenta and umbilical cord, they are convenient and simple and will not cause harm to the mother and fetus. Because they are less contaminated, they are more pure and more active. In addition to having the common properties of stem cells, mesenchymal stem cells are less immunogenic and are a good choice for transplantation treatment. In addition, the "regenerative properties" and "healing properties" of mesenchymal stem cells have brought new light and hope to the treatment of human diseases. Due to their unique advantages, mesenchymal stem cells have become a potential stock in the treatment of various clinical diseases and are deeply affecting the development of modern medicine.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Umbilical Cord Blood Stem Cells Storage market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Cells4Life
CellSave
Norton Healthcare
Cord for Life
Cryolife
IVF Riga Stem Cell Center
CBR
Cell Care
Cryo-Cell
Americord
MiracleCord
GeneCell
Bioscience
Cordlife
Cell Genesis
Cryonine
VCANBIO
Beike Biotechnology
H&B
BGI CELL
SALIAI
ICELL
Jiyuan Biotechnology
Boyalife
S-Evans Biosciences
Zhengda Stem Cell Bank
Liaoning Huize Health Biotechnology
Supercell Biotechnology
Guangxi Academy of Sciences Cell Bank
Bailing Stem Cell
Sunflower
Omnigen
LifeCell
ViaCord
Segment by Type
Umbilical Cord Mesenchymal Stem Cells
Perinatal Hematopoietic Stem Cells
Placental Stem Cells
Anti-Tumor Treatment
Antibacterial Treatment
Antiviral Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Umbilical Cord Blood Stem Cells Storage market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Umbilical Cord Blood Stem Cells Storage introduction, etc. Umbilical Cord Blood Stem Cells Storage Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Umbilical Cord Blood Stem Cells Storage market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Global Umbilical Cord Blood Stem Cells Storage market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Anti-Tumor Treatment and Antibacterial Treatment are the major drivers for the industry."&
Mesenchymal stem cells are widely present in human tissues and organs, especially in fetal perinatal tissues (placenta, umbilical cord, etc.). They are very abundant and have very low immunogenicity. And because neonatal stem cells are mainly derived from the placenta and umbilical cord, they are convenient and simple and will not cause harm to the mother and fetus. Because they are less contaminated, they are more pure and more active. In addition to having the common properties of stem cells, mesenchymal stem cells are less immunogenic and are a good choice for transplantation treatment. In addition, the "regenerative properties" and "healing properties" of mesenchymal stem cells have brought new light and hope to the treatment of human diseases. Due to their unique advantages, mesenchymal stem cells have become a potential stock in the treatment of various clinical diseases and are deeply affecting the development of modern medicine.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Umbilical Cord Blood Stem Cells Storage market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Cells4Life
CellSave
Norton Healthcare
Cord for Life
Cryolife
IVF Riga Stem Cell Center
CBR
Cell Care
Cryo-Cell
Americord
MiracleCord
GeneCell
Bioscience
Cordlife
Cell Genesis
Cryonine
VCANBIO
Beike Biotechnology
H&B
BGI CELL
SALIAI
ICELL
Jiyuan Biotechnology
Boyalife
S-Evans Biosciences
Zhengda Stem Cell Bank
Liaoning Huize Health Biotechnology
Supercell Biotechnology
Guangxi Academy of Sciences Cell Bank
Bailing Stem Cell
Sunflower
Omnigen
LifeCell
ViaCord
Segment by Type
Umbilical Cord Mesenchymal Stem Cells
Perinatal Hematopoietic Stem Cells
Placental Stem Cells
Segment by Application
Anti-Tumor Treatment
Antibacterial Treatment
Antiviral Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Umbilical Cord Blood Stem Cells Storage market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Umbilical Cord Blood Stem Cells Storage introduction, etc. Umbilical Cord Blood Stem Cells Storage Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Umbilical Cord Blood Stem Cells Storage market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices